Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E
about
Immunoprotection of mice against Schistosomiasis mansoni using solubilized membrane antigensA very high infection intensity of Schistosoma mansoni in a Ugandan Lake Victoria Fishing Community is required for association with highly prevalent organ related morbidityCytokine responses to the anti-schistosome vaccine candidate antigen glutathione-S-transferase vary with host age and are boosted by praziquantel treatmentEffect of praziquantel treatment of Schistosoma mansoni during pregnancy on intensity of infection and antibody responses to schistosome antigens: results of a randomised, placebo-controlled trialEffect of praziquantel treatment during pregnancy on cytokine responses to schistosome antigens: results of a randomized, placebo-controlled trial.Chronic hepatosplenomegaly in African school children: a common but neglected morbidity associated with schistosomiasis and malaria.Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL-5 and IL-10 levels depend upon age and infection status.Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel.Rapidly boosted Plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils.Immunology of human schistosomiasis.Effective anthelmintic therapy of residents living in endemic area of high prevalence for Hookworm and Schistosoma mansoni infections enhances the levels of allergy risk factor anti-Der p1 IgE.A late IL-33 response after exposure to Schistosoma haematobium antigen is associated with an up-regulation of IL-13 in human eosinophils.Multivariable Regression Analysis in Schistosoma mansoni-Infected Individuals in the Sudan Reveals Unique Immunoepidemiological Profiles in Uninfected, egg+ and Non-egg+ Infected IndividualsSpatial awareness in parasite immuno-epidemiology.Cytokine Pattern of T Lymphocytes in Acute Schistosomiasis mansoni Patients following Treated Praziquantel Therapy.Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis.T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatmentHuman eosinophils modulate peripheral blood mononuclear cell response to Schistosoma mansoni adult worm antigen in vitroComparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda.Change in children's school behavior after mass administration of praziquantel for Schistosoma mansoni infection in endemic areas of western Kenya: A pilot study using the Behavioral Assessment System for Children (BASC-2).Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.The effect of single dose versus two doses of praziquantel on Schistosoma haematobium infection and pathology among school-aged children in Mali.The Interdependence between Schistosome Transmission and Protective Immunity
P2860
Q27305172-D6F173BA-7BE7-4B92-9F07-0AEAB2089B67Q28534849-DECF8612-C4BB-4D72-A9B9-B5F112F97F14Q28538582-3AF19700-8A43-4184-8952-A0CA3326475FQ33419492-BD4B7E0B-394A-4B1B-92A6-4981F7B387EDQ33941725-59DA2494-0B87-4DB3-8550-3EE8779A5B4DQ34017976-523B3592-18EE-46A7-B62F-C9DC7FDBD998Q34551221-8B517C20-1B6E-4DDC-9300-527CE2280159Q34601522-A4C351A6-E8D4-427F-8A78-2B964B4D0516Q34654313-A8EDC393-8E28-4658-AFDF-F0C58BF315D8Q34782228-B5460714-8DD0-4512-8C9C-3CDE62F1886BQ35501629-EC25B47E-9C0B-40C1-9E5A-CBDED633821AQ35724182-DA4257AC-D2F6-4A70-AF35-D4C5C26012E7Q36010705-A2858344-7883-40C2-9B8F-1CC905880805Q36072566-A838D803-BA96-4FA2-B5AA-8B8458A7FE38Q36584302-229AF92E-A7AD-4804-BD97-7DC400C69C17Q36882459-8681C366-37B6-422A-A185-42130D16189BQ37014921-E09F0FD3-3D4E-4286-8F5D-D8D518F75B8AQ37152231-40ED13EF-16D0-4198-B512-742FA9A18389Q38452776-F099A433-9126-46ED-AFEA-F390DF854A15Q38660139-B16C09E6-33FB-42CA-926A-3E52045006EDQ40079529-EDC18050-5E96-4546-A41C-37DB2B233443Q46090821-C96EA52E-48F0-4310-9ED2-932630D88F8BQ57152572-71F1776F-7EFF-41C6-8501-A5765253581A
P2860
Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Chemotherapy for schistosomias ...... worm-specific immunoglobulin E
@ast
Chemotherapy for schistosomias ...... worm-specific immunoglobulin E
@en
Chemotherapy for schistosomias ...... worm-specific immunoglobulin E
@nl
type
label
Chemotherapy for schistosomias ...... worm-specific immunoglobulin E
@ast
Chemotherapy for schistosomias ...... worm-specific immunoglobulin E
@en
Chemotherapy for schistosomias ...... worm-specific immunoglobulin E
@nl
prefLabel
Chemotherapy for schistosomias ...... worm-specific immunoglobulin E
@ast
Chemotherapy for schistosomias ...... worm-specific immunoglobulin E
@en
Chemotherapy for schistosomias ...... worm-specific immunoglobulin E
@nl
P2093
P2860
P50
P921
P1476
Chemotherapy for schistosomias ...... worm-specific immunoglobulin E
@en
P2093
Birgitte J Vennervald
Claus M Reimert
Colin M Fitzsimmons
Edridah M Tukahebwa
Frances M Jones
Francis Kazibwe
Gachuhi Kimani
Henry C Kariuki
John H Ouma
Joseph K Mwatha
P2860
P304
P356
10.1128/IAI.72.7.4023-4030.2004
P407
P577
2004-07-01T00:00:00Z